Medibio_Logo.JPG
Scientific breakthrough on objective diagnosis of PTSD
June 26, 2017 10:40 ET | Medibio Limited
Scientific breakthrough for non-invasive, automatic, objective diagnosis of PTSD leveraging autonomic biomarkersAccuracy of 80% (+/- 1%) for objectively diagnosing subjects with PTSDMedibio has...
BrainsWay 2021 logo.jpg
Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression
June 22, 2017 17:12 ET | Brainsway Ltd.
HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today...
BrainsWay 2021 logo.jpg
CORRECTING and REPLACING – Brainsway Reports Strong Momentum in Q1 for 2017
June 08, 2017 17:09 ET | Brainsway Ltd.
HACKENSACK, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline on June 6th by Brainsway Ltd. (TASE:BRIN), please note in the fifth paragraph, the third...
BrainsWay 2021 logo.jpg
Brainsway Reports Strong Momentum in Q1 for 2017
June 06, 2017 13:20 ET | Brainsway Ltd.
HACKENSACK, N.J., June 06, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced...
PALI.jpg
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder
May 17, 2017 16:05 ET | Neuralstem, Inc.
GERMANTOWN, Md., May 17, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, today announced it has...
PALI.jpg
Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update
May 10, 2017 16:05 ET | Neuralstem, Inc.
GERMANTOWN, Md., May 10, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, reported its financial...
New Patent on Software as a Therapeutic for Depression and other Disorders
April 18, 2017 08:00 ET | Posit Science
SAN FRANCISCO, April 18, 2017 (GLOBE NEWSWIRE) -- The US Patent Office has issued a comprehensive patent to Posit Science for inventions utilizing brain training software to address depression, mood...
Telemynd.png
MYnd Analytics Announces Addition of Donald D’Ambrosio as Chief Financial Officer
April 03, 2017 08:30 ET | MYnd Analytics, Inc.
NEW YORK, April 03, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive medicine company which brings objective physical findings to psychiatric treatment in order to reduce...
Telemynd.png
MYnd Analytics Announces a Strategic One Million Dollar Equity Investment
March 21, 2017 08:30 ET | MYnd Analytics, Inc.
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive medicine company which brings objective physical findings to psychiatric treatment in order to reduce...
Hit Songwriter, Bestselling Author and Clinical Psychotherapist, Seth Swirsky, Set to Release '21 Ways to a Happier Depression' (Sourcebooks) -- a Creative, Watercolor-Filled, One-of-a-Kind Self Help Book
March 08, 2017 11:00 ET | Author Seth Swirsky
LOS ANGELES, CA--(Marketwired - March 08, 2017) - Seth Swirsky may already be on your radar if you love pop music. He wrote the #1 smash hit song, "Tell It To My Heart," for Taylor Dayne amongst many...